Literature DB >> 24655902

Surgical wound infection rates in Spain: data summary, January 1997 through June 2012.

Cristina Díaz-Agero Pérez1, Ana Robustillo Rodela2, María José Pita López3, Nieves López Fresneña2, Vicente Monge Jodrá4.   

Abstract

BACKGROUND: The Indicadores Clínicos de Mejora Continua de la Calidad (INCLIMECC) program was established in Spain in 1997.
METHODS: INCLIMECC is a prospective system of health care-associated infection (HAI) surveillance that collects incidence data in surgical and intensive care unit patients. The protocol is based on the National Healthcare Safety Network (NHSN) surveillance system, formerly known as the National Nosocomial Infection Surveillance (NNIS) system, and uses standard infection definitions from the US Centers for Disease Control and Prevention. Each hospital takes part voluntarily and selects the units and surgical procedures to be surveyed.
RESULTS: This report is a summary of the data collected between January 1997 and June 2012. A total of 370,015 patients were included, and the overall incidence of surgical wound infection (SWI) was 4.51%. SWI rates are provided by NHSN operating procedure category and NNIS risk index category. More than 27% of the patients received inadequate antibiotic prophylaxis, the main reason being unsuitable duration (57.05% of cases).
CONCLUSIONS: Today, the INCLIMECC network includes 64 Spanish hospitals. We believe that an HAI surveillance system with trained personnel external to the surveyed unit is a key component not only in infection control and prevention, but also in a quality improvement system.
Copyright © 2014. Published by Mosby, Inc.

Entities:  

Keywords:  Antimicrobial prophylaxis; Health care–associated infection; Infection control; Surgical site infection; Surveillance

Mesh:

Year:  2014        PMID: 24655902     DOI: 10.1016/j.ajic.2013.12.016

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  1 in total

1.  [Prophylactic antibiotherapy in hip arthroplasty. Cohort study].

Authors:  M Garrote-Garrote; J A Del-Moral-Luque; A Checa-García; J F Valverde-Cánovas; C Campelo-Gutiérrez; J Martínez-Martín; A Gil-de-Miguel; G Rodríguez-Caravaca
Journal:  Rev Esp Quimioter       Date:  2018-03-14       Impact factor: 1.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.